Skip to main content
Log in

The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons

  • Nephrology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

Chronic kidney disease (CKD) is a major public health problem worldwide, due to its epidemic proportions and to its association with high cardiovascular risk. Therefore, screening for CKD is an increasingly important concept, aiming for early detection and prevention of progression and complications of this disease.

Materials and methods

We studied the prevalence of CKD in the adult population of Iaşi, the largest county in Romania, based on the results of a national general health screening program from 2007 to 2008. The patients were tested for CKD with serum creatinine and urinary dipstick. We used two different methods to estimate the glomerular filtration rate (eGFR): the simplified Modification of Diet in Renal Disease (MDRD) and the CKD Epidemiology Collaboration (CKD-EPI) equations. Based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, we defined CKD as the presence of either eGFR < 60 ml/min/1.73 m2 and/or dipstick proteinuria. The classification of CKD by stage was also done according to the KDIGO criteria.

Results

The study population included 60,969 people. The global prevalence of CKD was found to be 6.69% by the MDRD formula and 7.32% when using the CKD-EPI equation. The prevalence of CKD was much higher in women than in men: 9.09% versus 3.7%, by MDRD, and 9.32% versus 4.85%, by CKD-EPI. By age groups, the prevalence of CKD was 0.95% and 0.64% in persons aged 18–44 years old, 4.27% and 3.57% (45–64 years old), 13.36% and 15.34% (65–79 years old), and 23.59% and 34.56% (>80 years old), according to MDRD and CKD-EPI, respectively. By stages, the prevalence of CKD stage 3a (eGFR 59 to 45 ml/min/1.73 m2) was 5.72% by MDRD and 5.96% according to CKD-EPI, whereas the prevalence of stages 3b, 4, and 5 taken together (eGFR < 45 ml/min/1.73 m2) was 0.96% (MDRD) and 1.35% (CKD-EPI). Patients with CKD were significantly older (71.0 years versus 53.7 years) and had lower levels of serum Hb, total cholesterol, and glutamic pyruvic transaminase, and significantly higher serum creatinine and blood glucose, in comparison with the individuals without CKD. Impaired fasting glucose (106 mg/dl) was found in the CKD population, but not in non-CKD individuals.

Conclusions

Our study is one of the largest ever reported on the prevalence of CKD worldwide, the first one in Romania, and one of the very few of its kind in Europe (particularly in Eastern Europe). The study showed that the prevalence of CKD in our country is around 7%, which is lower than in other countries; however, this could be underestimated due to population selection bias. The prevalence is similar with the MDRD and the CKD-EPI equations; it increases with age and is much higher in women than in men. Impaired fasting glucose was detected in CKD patients, a finding that should probably raise the awareness of the high cardiovascular risk associated with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stenvinkel P (2010) Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 268:456–467

    Article  PubMed  CAS  Google Scholar 

  2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G (2007) Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72:247–259

    Article  PubMed  CAS  Google Scholar 

  3. Whaley-Connell AT, Sowers JR, Stevens LA, McFarlane SI, Shlipak MG, Norris KC, Chen SC, Qiu Y, Wang C, Li S, Vassalotti JA, Collins AJ (2008) Kidney Early Evaluation Program Investigators. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis 51(4 Suppl 2):S13–S20

    Article  PubMed  CAS  Google Scholar 

  4. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F (2009) High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health 31(9):44

    Article  Google Scholar 

  5. Prodjosudjadi W, Suhardjono KS, Pranawa, Widiana IG, Loekman JS, Nainggolan G, Prasanto H, Wijayanti Y, Dharmeizar SM, Nasution MY, Basuki W, Aditiawardana, Harris DC, Pugsley DJ, Working Group of the Indonesian Society of Nephrology (2009) Detection and prevention of chronic kidney disease in Indonesia: initial community screening. Nephrology (Carlton) 14(7):669–674

    Article  Google Scholar 

  6. Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y, Fan Q (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24(7):2117–2123

    Article  PubMed  Google Scholar 

  7. Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, Ongaiyooth L, Vanavanan S, Sirivongs D, Thirakhupt P, Mittal B, Singh AK, Thai-SEEK Group (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25:1567–1575

    Article  PubMed  Google Scholar 

  8. Kim S, Lim CS, Han DC, Kim GS, Chin HJ, Kim SJ, Cho WY, Kim YH, Kim YS (2009) The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci 24(Suppl):S11–S21

    Article  PubMed  CAS  Google Scholar 

  9. Bastos RM, Bastos MG, Ribeiro LC, Bastos RV, Teixeira MT (2009) Prevalence of chronic kidney disease, stages 3, 4 and 5 in adults. Rev Assoc Med Bras 55:40–44

    Article  PubMed  Google Scholar 

  10. Vassalotti JA, Li S, Chen SC, Collins AJ (2009) Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 53(3):S107–S114

    Article  PubMed  Google Scholar 

  11. New JP, Middleton RJ, Klebe B, Farmer CK, de Lusignan S, Stevens PE, O’Donoghue DJ (2007) Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 24:364–369

    Article  PubMed  CAS  Google Scholar 

  12. McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL, KEEP Investigators (2008) Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality. Am Heart J 156:277–283

    Article  PubMed  Google Scholar 

  13. Hallan SI, Stevens P (2010) Screening for chronic kidney disease: which strategy? J Nephrol 23:147–155

    PubMed  Google Scholar 

  14. Public Health Department and National House Insurance Order no. 994/354 regarding the approval of methodological norms for performing and reporting specific activities within the National Program for the Evaluation of the Population’s Health State in Primary Care. Official Journal of Romania no. 409, 19 June 2007

  15. Levey AS, Greene T, Kusek J, Beck GJ, Group MS (2000) A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 11:A0828

    Google Scholar 

  16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    PubMed  Google Scholar 

  17. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100

    Article  PubMed  Google Scholar 

  18. Zoccali C, Kramer A, Jager KJ (2010) Chronic kidney disease and end-stage renal disease: a review produced to contribute to the report ‘the status of health in the European Union: towards a healthier Europe’. NDT Plus 3:213–224

    Article  Google Scholar 

  19. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C (2008) Screening for chronic kidney disease: Where does Europe go? Clin J Am Soc Nephrol 3:616–623

    Article  PubMed  Google Scholar 

  20. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 139:137–147

    PubMed  Google Scholar 

  21. De Zeeuw D, Hillege HL, de Jong PE (2005) The kidney, a cardiovascular risk marker and a new target for therapy. Kidney Int 68(Supp 98):S25–S29

    Article  Google Scholar 

  22. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan H, Lydersen S, Holmen J (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17:2275–2284

    Article  PubMed  Google Scholar 

  23. Otero A, Gayoso P, Garcia F, de Francisco AL, on behalf of the EPIRCE study group (2005) Epidemiology of chronic renal disease in the Galician population: Results of the pilot Spanish EPIRCE study. Kidney Int 68(Supp 99):S16–S19

    Article  Google Scholar 

  24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470

    PubMed  CAS  Google Scholar 

  25. Levey AS, Greene T, Kusek J, Beck GJ, Group MS (2000) A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 11:A0828

    Google Scholar 

  26. Rule AD (2010) The CKD-EPI Equation for Estimating GFR from Serum Creatinine: Real Improvement or More of the Same? Clin J Am Soc Nephrol 5:951–953

    Article  PubMed  Google Scholar 

  27. Poggio ED, Wang X, Greene T, Van Lente F (2005) Hall PM: Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 16:459–466

    Article  PubMed  Google Scholar 

  28. Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W (2005) An alternative formula to the Cockcroft-Gault and the Modification of Diet in Renal Disease formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol 16:1051–1060

    Article  PubMed  Google Scholar 

  29. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG (2004) Using serum creatinine to estimate glomerular filtration rate: Accuracy in good health and in chronic kidney disease. Ann Intern Med 141:929–937

    PubMed  CAS  Google Scholar 

  30. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    PubMed  Google Scholar 

  31. Levey AS, Stevens LA (2010) Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55(4):622–627

    Article  PubMed  Google Scholar 

  32. Fesler P, Mimran A (2010) Estimation of glomerular filtration rate: What are the pitfalls? Curr Hypertens Rep 2011 Jan 5. [Epub ahead of print]

  33. Schold JD, Navaneethan SD, Jolly SE, Poggio ED, Arrigain S, Saupe W, Jain A, Sharp JW, Simon JF, Schreiber MJ Jr, Nally JV Jr. (2010) Implications of the CKD-EPI GFR Estimation Equation in Clinical Practice. Clin J Am Soc Nephrol 29. [Epub ahead of print]

  34. Delanaye P, Cavalier E, Mariat C, Maillard N, Krzesinski JM (2010) MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrol 11:8

    Article  PubMed  Google Scholar 

  35. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J (2010) Risk implications of the new Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis 55(4):648–659

    Article  PubMed  Google Scholar 

  36. Banerjee D, Contreras G, Jaraba I, Carvalho D, Ortega L, Carvalho C, Pezon C, Rosenthal SP, De La Rosa N, Vemuri N, Cherla G, Nahar N (2009) Chronic kidney disease stages 3–5 and cardiovascular disease in the veterans affairs population. Int Urol Nephrol 41:443–451

    Article  PubMed  Google Scholar 

  37. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23(5):469–480

    Article  PubMed  CAS  Google Scholar 

  38. Guarnieri G, Zanetti M, Vinci P, Cattin MR, Pirulli A, Barazzoni R (2010) Metabolic syndrome and chronic kidney disease. J Ren Nutr 20(5 Supp):S19–S23

    Article  PubMed  CAS  Google Scholar 

  39. Whaley-Connell A, Pavey BS, McCullough PA, Saab G, Li S, McFarlane SI, Chen SC, Vassalotti JA, Collins AJ, Bakris G, Sowers JR, KEEP Investigators (2010) Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Clin Hypertens (Greenwich) 12:51–58

    Article  Google Scholar 

  40. Yoon YS, Park HS, Yun KE, Kim SB (2009) Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults. Metabolism 58:1737–1742

    Article  PubMed  CAS  Google Scholar 

  41. Ritz E (2008) Metabolic syndrome and kidney disease. Blood Purif 26:59–62

    Article  PubMed  CAS  Google Scholar 

  42. American Diabetes Association (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(suppl 1):S5–S20

    Google Scholar 

  43. Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398

    Article  PubMed  CAS  Google Scholar 

  44. Cano NJ, Miolane-Debouit M, Léger J, Heng AE (2009) Assessment of body protein: energy status in chronic kidney disease. Semin Nephrol 29:59–66

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liviu Segall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cepoi, V., Onofriescu, M., Segall, L. et al. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons. Int Urol Nephrol 44, 213–220 (2012). https://doi.org/10.1007/s11255-011-9923-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-9923-z

Keywords

Navigation